BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kitani-Morii F, Kasai T, Horiguchi G, Teramukai S, Ohmichi T, Shinomoto M, Fujino Y, Mizuno T. Risk factors for neuropsychiatric symptoms in patients with Parkinson's disease during COVID-19 pandemic in Japan. PLoS One 2021;16:e0245864. [PMID: 33481879 DOI: 10.1371/journal.pone.0245864] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Afraie M, Moradi G, Mohammadzedeh P, Azami M, Riyahifar S, Moradi Y. COVID-19 and Parkinson’s disease: a systematic review and meta-analysis. Acta Neurol Belg 2022. [DOI: 10.1007/s13760-022-02141-6] [Reference Citation Analysis]
2 Nam S, Lee N, Kim EY. Living with a Pandemic from Psycho-Social Perspectives: A Narrative Review. Iran J Public Health 2022;51:2472-83. [PMID: 36561263 DOI: 10.18502/10.18502/ijph.v51i11.11164] [Reference Citation Analysis]
3 Rippon D, Hand A, Dismore L, Caiazza R. The Impact of the COVID-19 Pandemic on Informal Caregivers of People With Parkinson's Disease Residing in the UK: A Qualitative Study. J Geriatr Psychiatry Neurol 2022;:8919887221135555. [PMID: 36268777 DOI: 10.1177/08919887221135555] [Reference Citation Analysis]
4 Shaheen S, Ali RM, Farghaly M, El-serafy O, Hegazy MI. Screening for non-motor symptoms in Egyptian patients with Parkinson’s disease. Egypt J Neurol Psychiatry Neurosurg 2022;58:103. [DOI: 10.1186/s41983-022-00541-2] [Reference Citation Analysis]
5 Irrera N, Barbieri MA, Bagnato G, Ioppolo C, Versace AG. Impact of the COVID-19 Pandemic on Chronic Neurological Disorders: Focus on Patients with Dementia. CNSNDDT 2022;21:1017-1026. [DOI: 10.2174/1871527321666220111124928] [Reference Citation Analysis]
6 Mameli F, Zirone E, Capetti B, Mellace D, Ferrucci R, Franco G, Di Fonzo A, Barbieri S, Ruggiero F. Changes in non-motor symptoms in patients with Parkinson's disease following COVID-19 pandemic restrictions: A systematic review. Front Psychol 2022;13:939520. [DOI: 10.3389/fpsyg.2022.939520] [Reference Citation Analysis]
7 Gaigher JM, Lacerda IB, Dourado MCN. Dementia and Mental Health During the COVID-19 Pandemic: A Systematic Review. Front Psychiatry 2022;13:879598. [DOI: 10.3389/fpsyt.2022.879598] [Reference Citation Analysis]
8 Tufail M, Wu C. Psychological impact of COVID-19 pandemic on Parkinson's disease patients. Heliyon 2022;8:e09604. [DOI: 10.1016/j.heliyon.2022.e09604] [Reference Citation Analysis]
9 Lingor P, Demleitner AF, Wolff AW, Feneberg E. SARS-CoV-2 and neurodegenerative diseases: what we know and what we don’t. J Neural Transm. [DOI: 10.1007/s00702-022-02500-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
10 Valdovinos BY, Modica JS, Schneider RB. Moving Forward from the COVID-19 Pandemic: Needed Changes in Movement Disorders Care and Research. Curr Neurol Neurosci Rep 2022. [PMID: 35107786 DOI: 10.1007/s11910-022-01178-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Mcdaniels B, Subramanian I. Social isolation, loneliness and mental health sequelae of the Covid-19 pandemic in Parkinson's disease. International Review of Neurobiology 2022. [DOI: 10.1016/bs.irn.2022.03.003] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Aminabad ED, Mobed A, Hasanzadeh M, Hosseinpour Feizi MA, Safaralizadeh R, Seidi F. Sensitive immunosensing of α-synuclein protein in human plasma samples using gold nanoparticles conjugated with graphene: an innovative immuno-platform towards early stage identification of Parkinson's disease using point of care (POC) analysis. RSC Adv 2022;12:4346-57. [DOI: 10.1039/d1ra06437a] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
13 Rota S, Boura I, Wan Y, Lazcano-ocampo C, Rodriguez-violante M, Antonini A, Chaudhuri KR. Spotlight on non-motor symptoms and Covid-19. International Review of Neurobiology 2022. [DOI: 10.1016/bs.irn.2022.04.001] [Reference Citation Analysis]
14 Krey L, Huber MK, Höglinger GU, Wegner F. Can SARS-CoV-2 Infection Lead to Neurodegeneration and Parkinson's Disease? Brain Sci 2021;11:1654. [PMID: 34942956 DOI: 10.3390/brainsci11121654] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
15 Ciuffreda G, Cabanillas-Barea S, Carrasco-Uribarren A, Albarova-Corral MI, Argüello-Espinosa MI, Marcén-Román Y. Factors Associated with Depression and Anxiety in Adults ≥60 Years Old during the COVID-19 Pandemic: A Systematic Review. Int J Environ Res Public Health 2021;18:11859. [PMID: 34831615 DOI: 10.3390/ijerph182211859] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
16 Kaur H, Poon PK, Wang SY, Woodbridge DM. Depression Level Prediction in People with Parkinson’s Disease during the COVID-19 Pandemic. 2021 43rd Annual International Conference of the IEEE Engineering in Medicine & Biology Society (EMBC) 2021. [DOI: 10.1109/embc46164.2021.9630566] [Reference Citation Analysis]
17 Dommershuijsen LJ, Van der Heide A, Van den Berg EM, Labrecque JA, Ikram MK, Ikram MA, Bloem BR, Helmich RC, Darweesh SKL. Mental health in people with Parkinson's disease during the COVID-19 pandemic: potential for targeted interventions? NPJ Parkinsons Dis 2021;7:95. [PMID: 34711842 DOI: 10.1038/s41531-021-00238-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
18 Brooks SK, Weston D, Greenberg N. Social and psychological impact of the COVID-19 pandemic on people with Parkinson's disease: a scoping review. Public Health 2021;199:77-86. [PMID: 34571441 DOI: 10.1016/j.puhe.2021.08.014] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
19 Suzuki K, Numao A, Komagamine T, Haruyama Y, Kawasaki A, Funakoshi K, Fujita H, Suzuki S, Okamura M, Shiina T, Hirata K. Impact of the COVID-19 Pandemic on the Quality of Life of Patients with Parkinson's Disease and Their Caregivers: A Single-Center Survey in Tochigi Prefecture. J Parkinsons Dis 2021;11:1047-56. [PMID: 33780375 DOI: 10.3233/JPD-212560] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 9.5] [Reference Citation Analysis]